UK registered businesses can apply for a share of up to £10 million to develop next generation immunotherapies for cancer or life-changing treatments for paediatric cancers.
Eligibility summary
This competition is open to single applicants and collaborations.
To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise.